PSMA Polyclonal Antibody

Background:
Prostate-specific membrane antigen (PSMA) is expressed in normal and malignant prostatic epithelium and in a subset of non-prostatic tissues. In prostate cancer, PSMA expression has been shown to correlate with disease progression, with highest levels expressed in hormone-refractory and metastatic disease. The cellular localization of PSMA is cytoplasmic and/or membranous.

Research Area: Signal Transduction, Cancer, Metabolism

Synonyms:
Cell growth inhibiting protein 27, Cell growth-inhibiting gene 27 protein, FGCP, Folate hydrolase 1, Folate hydrolase, Folate hydrolase prostate specific membrane antigen 1, FOLH 1, FOLH, Folh1, FOLH1, Folylpoly gamma glutamate carboxypeptidase, GCP2, GCPII, GIG27, Glutamate carboxypeptidase 2, Glutamate carboxypeptidase II, Membrane glutamate carboxypeptidase, mGCP, N acetylated alpha linked acidic dipeptidase 1, NAALAD 1, NAALADase I, Prostate specific membrane antigen variant F, Prostate-specific membrane antigen, PSM, PSMA, Pteroylpoly gamma glutamate carboxypeptidase

Immunogen: Recombinant Human Glutamate carboxypeptidase 2 protein

Swissprot: Q04609
Gene ID: 2346

Calculated MW: 9,12,50,78,80,82,84 kDa
Observed MW: 80 kDa

Purification Method: Antigen Affinity Purification

Buffer: PBS with 0.05% Proclin300, 50% glycerol, pH7.3

Concentration: 0.54 mg/mL
Dilution: WB 1:500-1:1000 IHC 1:100-1:300

Storage:
Store at -20°C. Avoid freeze / thaw cycles.